We are live on ! Find out more
RXDX

Prometheus Biosciences, Inc. Common Stock

Delisted

RXDX was delisted on the 15th of June, 2023.

Name Holding Trade Value Shares
Change
Change in
Stake
EAM
1
Eventide Asset Management
Massachusetts
$88.2M
PA
2
Perceptive Advisors
New York
$81.4M
RI
3
RTW Investments
New York
$76M
CA
4
CHI Advisors
New York
$70M -$491K -22,023 -0.8%
7IH
5
72 Investment Holdings
Connecticut
$45.4M
CAM
6
Cormorant Asset Management
Massachusetts
$44.5M -$5.58M -250,000 -12%
BlackRock
7
BlackRock
New York
$23.1M +$13.2M +593,261 +172%
Point72 Asset Management
8
Point72 Asset Management
Connecticut
$18.8M -$801K -35,898 -4%
SCM
9
Suvretta Capital Management
New York
$15.4M +$1.05M +47,091 +8%
RSCM
10
Rock Springs Capital Management
Maryland
$14.6M +$474K +21,238 +4%
Franklin Resources
11
Franklin Resources
California
$13.7M -$1.18M -52,704 -9%
Vanguard Group
12
Vanguard Group
Pennsylvania
$13.2M +$9.35M +419,361 +349%
Fidelity Investments
13
Fidelity Investments
Massachusetts
$10.1M -$3.2M -143,400 -26%
Norges Bank
14
Norges Bank
Norway
$9.63M
Adage Capital Partners
15
Adage Capital Partners
Massachusetts
$9.21M -$2.23M -100,000 -21%
PIM
16
Platinum Investment Management
Australia
$8.72M +$4.77M +213,753 +151%
O
17
OrbiMed
New York
$6.14M
Geode Capital Management
18
Geode Capital Management
Massachusetts
$5.17M +$4.3M +192,840 +1,085%
WP
19
Woodline Partners
California
$4.98M -$170K -7,642 -4%
HA
20
HHLR Advisors
Cayman Islands
$4.91M
OCA
21
Octagon Capital Advisors
New York
$4.91M
State Street
22
State Street
Massachusetts
$3.83M +$3.48M +155,801 New
Northern Trust
23
Northern Trust
Illinois
$2.72M +$2.47M +110,738 New
LP
24
LMR Partners
United Kingdom
$2.33M -$88.2K -3,955 -4%
Charles Schwab
25
Charles Schwab
California
$1.85M +$1.68M +75,128 New